K

Kliniksa Pharma (KNSA)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Kliniksa Pharma (KNSA)

Kiniksa Pharmaceuticals, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases. The Company’s progr... Read more

Open
USD26.54
High
USD26.62
Low
USD26.00
52 Week High
USD28.56
Monthly Return
30.30%
Revenue
481M

Avg. Daily Vol.
613.77k
Market Cap.
1.1B
52 Week Low
17.38
Annual Return
34.80%
Forward P/E
30.60%

Stock News

Person shot outside CIA headquarters by security guards

Person shot outside CIA headquarters by security guards

CNBC

Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

Yahoo

BJ’s Wholesale’s stock rises as outlook maintained, despite a sales miss and tariffs

BJ’s Wholesale’s stock rises as outlook maintained, despite a sales miss and tariffs

MarketWatch

Sam Altman's $6.4 billion bet on Jony Ive has Zuckerberg-like qualities

Sam Altman's $6.4 billion bet on Jony Ive has Zuckerberg-like qualities

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.